Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report

We report a fatal case of pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer. A 77-year-old man was aware of eye ptosis and diplopia after three weeks from first infusion of pembrolizumab, an anti-programmed cell death protein 1 monoclonal antibodies....

Descripción completa

Detalles Bibliográficos
Autores principales: Takai, Manabu, Kato, Daiki, Iinuma, Koji, Maekawa, Yuka Muramatsu, Nakane, Keita, Tsuchiya, Tomohiro, Yokoi, Shigeaki, Koie, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068635/
https://www.ncbi.nlm.nih.gov/pubmed/32190548
http://dx.doi.org/10.1016/j.eucr.2020.101145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068635/
https://www.ncbi.nlm.nih.gov/pubmed/32190548
http://dx.doi.org/10.1016/j.eucr.2020.101145

Ejemplares similares